Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter
AssigneeLipoScience, Inc.
InventorsJames D. Otvos, Irina Y. Shalaurova
Life of this patent
Estimating the term…
Abstract
Methods, systems and circuits evaluate a subject's CVD risk using a risk parameter that includes at least one HDL and inflammatory biomarker interaction parameter. The inflammatory biomarker may optionally comprise NMR derived measurements of GlycA from at least one biosample of the subject. The risk parameter may be gender-specific.
Claims20
A method of determining a risk parameter for cardiovascular disease or events, comprising:
- obtaining measurements of HDL particles and at least one inflammatory biomarker in a biosample from a subject;
- determining concentrations for at least one individual HDL particle size subclass and the at least one inflammatory biomarker, based on the measurements;
- and
- programmatically calculating a risk parameter ((HxI)CVD) of the subject using at least the concentrations for the at least one subclass of HDL particle and the at least one inflammatory biomarker.
A system for determining a risk parameter for cardiovascular disease or events, comprising:
- a component for obtaining measurements of HDL particles and at least one inflammatory biomarker in a biosample from a subject;
- a component for determining concentrations for at least one individual HDL particle size subclass and the at least one inflammatory biomarker, based on the measurements;
- and
- a component for programmatically calculating a risk parameter ((HxI)CVD) of the subject using at least the concentrations for the at least one subclass of HDL particle and the at least one inflammatory biomarker.
17-25. (canceled)
A computer program product for determining a risk parameter for cardiovascular disease or events, the computer program product comprising:
- a non-transitory computer readable storage medium having computer readable program code embodied in the medium, the computer-readable program code comprising:
- computer readable program code that obtains concentration measurements for at least eight subclasses of HDL-P in a blood plasma or serum sample and at least one inflammatory biomarker, and
- computer readable program code that calculates a risk parameter ((HxI)CVD) comprising at least one interaction parameter.
28-37. (canceled)
Dependencies are inferred from the claim text.